[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30. DOI: 10.3322/caac.21442. [2] Varghese F, Wong J.Breast Cancer in the Elderly[J]. Surg Clin North Am, 2018, 98(4): 819-833. DOI: 10.1016/j.suc.2018.04.002. [3] 陈照生. 血清SDF-1、CXCL5、CEA联合检测对乳腺癌的诊断价值[J]. 国际医药卫生导报, 2020, 26(8): 1119-1121. DOI: 10.3760/cma.j.issn.1007-1245.2020.08.025. [4] Zakhireh A, Saltzstein EC, Terreros DA.Ductal carcinoma in situ (DCIS) of the male breast[J]. Breast J, 2004, 10(3): 263-264. DOI: 10.1111/j.1075-122X.2004.21322.x. [5] 杨亚琛, 梅红. 数字乳腺X线用于乳腺导管原位癌的诊断价值[J]. 中国老年学杂志, 2017, 37(21): 5338-5339. DOI: 10.3969/j.issn.1005-9202.2017.21.054. [6] 武中林, 荣小翠, 赵俊京, 等. 全数字化X线摄影、超声及MRI对乳腺癌诊断价值的ROC曲线分析[J]. 临床放射学杂志, 2015, 34(3): 355-359. [7] Virnig BA, Tuttle TM, Shamliyan T, et al.Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes[J]. J Natl Cancer Inst, 2010, 102(3): 170-178. DOI: 10.1093/jnci/djp482. [8] Winchester DP, Jeske JM, Goldschmidt RA.The diagnosis and management of ductal carcinoma in-situ of the breast[J]. CA Cancer J Clin, 2000, 50(3): 184-200. DOI: 10.3322/canjclin.50.3.184. [9] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29. DOI: 10.3322/caac.21254. [10] Evans AJ, Pinder SE, Snead DR, et al.The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours[J]. Br J Cancer, 1997, 75(4): 542-544. DOI: 10.1038/bjc.1997.94. [11] 聂晨蕾, 易春蓓, 巩海燕, 等. 乳腺导管内癌及导管内癌伴微浸润的临床、病理及超声特征对比研究[J]. 中国肿瘤外科杂志, 2020, 12(1): 32-36. DOI: 10.3969/j.issn.1674-4136.2020.01.008. [12] Ozanne EM, Shieh Y, Barnes J, et al.Characterizing the impact of 25 years of DCIS treatment[J]. Breast Cancer Res Treat, 2011, 129(1): 165-173. DOI: 10.1007/s10549-011-1430-5. [13] Rakovitch E, Nofech-Mozes S, Hanna W, et al.A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone[J]. Breast Cancer Res Treat, 2015, 152(2): 389-398. DOI: 10.1007/s10549-015-3464-6. [14] 王小娟. 乳腺X线摄影在诊断乳腺导管内癌中的应用[J]. 实用医学影像杂志, 2020, 21(3): 328-330. DOI: 10.16106/j.cnki.cn14-1281/r.2020.02.051. [15] 郦畅园. 超声检查联合钼靶X线对乳腺导管内癌的早期诊断效果[J]. 影像研究与医学应用, 2020, 4(15): 174-175. [16] 李坤鹏, 刘慧. 彩超和钼靶检查对乳腺导管内乳头状瘤与导管内癌临床诊断的价值分析[J]. 临床外科杂志, 2020, 28(5): 464-466. DOI: 10.3969/j.issn.1005-6483. 2020. 05.019. [17] 赵淳, 许华宁, 沈碧潇, 等. 超声图像及造影特征对乳腺导管内癌的早期诊断价值[J]. 东南大学学报(医学版), 2020, 39(3): 293-297. DOI: 10.3969/j.issn.1671-6264. 2020. 03.008. [18] 聂晨蕾, 苏彤, 易春蓓, 等. 单纯性乳腺导管内癌的超声声像图特征及病理学特征分析研究[J]. 肿瘤影像学, 2020, 29(2): 134-140. DOI: 10.19732/j.cnki.2096-6210. 2020. 02.011. [19] 李二妮, 胡满仓, 田原, 等. 乳腺恶性微钙化MRI诊断的敏感性及其影响因素[J]. 实用放射学杂志, 2020, 36(1): 53-56, 114. DOI: 10.3969/j.issn.1002-1671.2020.01.014. |